Zu‐Yao Yang

5.3k total citations · 2 hit papers
95 papers, 3.6k citations indexed

About

Zu‐Yao Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zu‐Yao Yang has authored 95 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Zu‐Yao Yang's work include Colorectal Cancer Treatments and Studies (13 papers), Climate Change and Health Impacts (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Zu‐Yao Yang is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Climate Change and Health Impacts (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Zu‐Yao Yang collaborates with scholars based in China, Hong Kong and United Kingdom. Zu‐Yao Yang's co-authors include Chen Mao, Jin-Ling Tang, Jin-Qiu Yuan, Jinling Tang, Xiaohong Fu, Yuelun Zhang, Diane Threapleton, Kaifeng Wang, Xiaoran Han and Xinyin Wu and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Neurology.

In The Last Decade

Zu‐Yao Yang

87 papers receiving 3.5k citations

Hit Papers

The prevalence of EGFR mutation in patients with non-smal... 2016 2026 2019 2022 2016 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
    2016 537 citations Yuelun Zhang, Jin-Qiu Yuan et al. profile →
  2. Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
    2023 68 citations Zhirong Yang, Di Liu et al. The Lancet Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zu‐Yao Yang China 33 1.1k 1.0k 570 534 409 95 3.6k
Iona Cheng United States 40 1.5k 1.4× 1.0k 1.0× 415 0.7× 1.0k 1.9× 729 1.8× 192 4.4k
Reina Haque United States 33 1.0k 1.0× 776 0.7× 1.2k 2.1× 639 1.2× 797 1.9× 116 4.4k
Eva Ardanáz Spain 38 1.7k 1.6× 798 0.8× 536 0.9× 579 1.1× 525 1.3× 142 5.2k
Denise Riedel Lewis United States 23 1.2k 1.1× 688 0.7× 446 0.8× 527 1.0× 352 0.9× 39 3.4k
Dae Ryong Kang South Korea 35 666 0.6× 1.0k 1.0× 308 0.5× 482 0.9× 310 0.8× 245 4.6k
Bin Huang United States 38 1.4k 1.3× 528 0.5× 347 0.6× 559 1.0× 611 1.5× 202 4.2k
Vladimí­r Janout Czechia 36 654 0.6× 900 0.9× 484 0.8× 1.4k 2.7× 629 1.5× 152 4.1k
Yujiao Deng China 32 822 0.8× 550 0.5× 233 0.4× 919 1.7× 659 1.6× 145 3.2k
John M. Hampton United States 41 2.5k 2.3× 610 0.6× 459 0.8× 530 1.0× 818 2.0× 122 4.8k
Nan Li China 36 796 0.7× 731 0.7× 520 0.9× 1.2k 2.3× 313 0.8× 288 5.0k

Countries citing papers authored by Zu‐Yao Yang

Since Specialization
Citations

This map shows the geographic impact of Zu‐Yao Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu‐Yao Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu‐Yao Yang more than expected).

Fields of papers citing papers by Zu‐Yao Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu‐Yao Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu‐Yao Yang. The network helps show where Zu‐Yao Yang may publish in the future.

Co-authorship network of co-authors of Zu‐Yao Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zu‐Yao Yang. A scholar is included among the top collaborators of Zu‐Yao Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu‐Yao Yang. Zu‐Yao Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chen, Lei, Zu‐Yao Yang, Shuming Ji, et al.. (2025). Comparing the Risk of Epilepsy in Patients With Simple Congenital Heart Diseases: A Prospective Cohort Study. CNS Neuroscience & Therapeutics. 31(2). e70230–e70230.
4.
Yang, Zu‐Yao, Yu Qian, Junyi Zhou, et al.. (2025). AI-based pathomics in kidney diseases: progress and application. Renal Failure. 47(1). 2598080–2598080.
5.
6.
Yang, Zu‐Yao & Jinling Tang. (2024). Definitions of chronic disease need to be more patient centred. BMJ. 387. q1858–q1858. 1 indexed citations
7.
Chen, Zhi, Bingjie Wang, Pauline Kang, et al.. (2023). Significant myopic shift over time: Sixteen-year trends in overall refraction and age of myopia onset among Chinese children, with a focus on ages 4-6 years. Journal of Global Health. 13. 4144–4144. 15 indexed citations
8.
Yang, Zhirong, Di Liu, Teng-Fei Lin, et al.. (2023). Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials. The Lancet Microbe. 4(4). e236–e246. 68 indexed citations breakdown →
9.
Wong, Duo Wai‐Chi, James Chung‐Wai Cheung, Jia‐Guo Zhao, Ming Ni, & Zu‐Yao Yang. (2023). Forefoot Function after Hallux Valgus Surgery: A Systematic Review and Meta-Analysis on Plantar Load Measurement. Journal of Clinical Medicine. 12(4). 1384–1384. 3 indexed citations
10.
Wang, Shuting, Zhirong Yang, Feng Sha, et al.. (2023). Prevalence of incidental colorectal cancer and polyps in autopsies of different populations: a systematic review with meta-regression analysis. European Journal of Epidemiology. 38(9). 939–955. 4 indexed citations
11.
Zhao, Shi, Zu‐Yao Yang, Salihu S. Musa, et al.. (2021). Attach importance of the bootstrapttest against Student'sttest in clinical epidemiology: a demonstrative comparison using COVID-19 as an example. Epidemiology and Infection. 149. e107–e107. 5 indexed citations
12.
Zhao, Shi, Biao Tang, Salihu S. Musa, et al.. (2021). Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data. Epidemics. 36. 100482–100482. 49 indexed citations
13.
Ran, Jinjun, Shi Zhao, Lefei Han, et al.. (2020). Effects of particulate matter exposure on the transmissibility and case fatality rate of COVID-19: A Nationwide Ecological Study in China. Journal of Travel Medicine. 27(6). 68 indexed citations
14.
Ma, Shujuan, Jiayue Zhang, Minyan Zeng, et al.. (2020). Epidemiological Parameters of COVID-19: Case Series Study. Journal of Medical Internet Research. 22(10). e19994–e19994. 33 indexed citations
15.
Zeng, Fangfang, Sui Zhu, Martin C. S. Wong, et al.. (2016). Associations between nitric oxide synthase 3 gene polymorphisms and preeclampsia risk: a meta-analysis. Scientific Reports. 6(1). 23407–23407. 19 indexed citations
16.
Yang, Li, Xiaohong Fu, Jin-Qiu Yuan, et al.. (2015). Colorectal cancer: using blood samples and tumor tissue to detectK-rasmutations. Expert Review of Anticancer Therapy. 15(6). 715–725. 5 indexed citations
17.
Mao, Chen, Xiaohong Fu, Jin-Qiu Yuan, et al.. (2015). Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention. Cochrane Database of Systematic Reviews. 2015(5). CD010237–CD010237. 32 indexed citations
18.
Huang, Yafang, Chen Mao, Jin-Qiu Yuan, et al.. (2014). Distribution and Epidemiological Characteristics of Published Individual Patient Data Meta-Analyses. PLoS ONE. 9(6). e100151–e100151. 13 indexed citations
19.
Yuan, Jin-Qiu, Yali Liu, Zu‐Yao Yang, et al.. (2013). The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews. Current Medical Research and Opinion. 29(3). 279–287. 33 indexed citations
20.
Yang, Zu‐Yao, Siyan Zhan, Bo Wang, et al.. (2010). [Fatality and secular trend of bloodstream infections during hospitalization in China: a systematic review and meta-analysis].. PubMed. 42(3). 304–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iona Cheng Breakdown of academic impact, for papers by Reina Haque Breakdown of academic impact, for papers by Eva Ardanáz Breakdown of academic impact, for papers by Denise Riedel Lewis Breakdown of academic impact, for papers by Dae Ryong Kang Breakdown of academic impact, for papers by Bin Huang Breakdown of academic impact, for papers by Vladimí­r Janout Breakdown of academic impact, for papers by Yujiao Deng Breakdown of academic impact, for papers by John M. Hampton Breakdown of academic impact, for papers by Nan Li
Rankless by CCL
2026